Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

1.

Health-related quality of life and cost-effectiveness studies in the European randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary trial.

Miller AB, Madalinska JB, Church T, Crawford D, Essink-Bot ML, Goel V, de Koning HJ, Määttänen L, Pentikäinen T.

Eur J Cancer. 2001 Nov;37(17):2154-60. Review.

PMID:
11677101
2.
3.

Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Schröder FH.

Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3. Review.

PMID:
15780157
4.
5.

The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews.

Black C, Bagust A, Boland A, Walker S, McLeod C, De Verteuil R, Ayres J, Bain L, Thomas S, Godden D, Waugh N.

Health Technol Assess. 2006 Jan;10(3):iii-iv, ix-x, 1-90. Review.

6.

Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.

Manser R, Dalton A, Carter R, Byrnes G, Elwood M, Campbell DA.

Lung Cancer. 2005 May;48(2):171-85. Epub 2005 Jan 4.

PMID:
15829317
7.

Cost-effectiveness of prostate specific antigen screening in the United States: extrapolating from the European study of screening for prostate cancer.

Shteynshlyuger A, Andriole GL.

J Urol. 2011 Mar;185(3):828-32. doi: 10.1016/j.juro.2010.10.079. Epub 2011 Jan 15.

PMID:
21239021
8.

[Cost effectiveness of screening procedures for early detection of prostatic carcinoma: an overview].

Mueller-Lisse UG, Mueller-Lisse UL.

Radiologe. 2002 Aug;42(8):601-7. Review. German.

PMID:
12426737
9.

The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise.

Andriole GL, Reding D, Hayes RB, Prorok PC, Gohagan JK; PLCO Steering Committee.

Urol Oncol. 2004 Jul-Aug;22(4):358-61.

PMID:
15283897
10.

The economic impact of false-positive cancer screens.

Lafata JE, Simpkins J, Lamerato L, Poisson L, Divine G, Johnson CC.

Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2126-32.

11.

Economic evaluation of prostate cancer screening with prostate-specific antigen.

Imamura T, Yasunaga H.

Int J Urol. 2008 Apr;15(4):285-8. doi: 10.1111/j.1442-2042.2008.02013.x. Review.

12.

Economic evaluation of screening for prostate cancer: a randomized population based programme during a 10-year period in Sweden.

Holmberg H, Carlsson P, Löfman O, Varenhorst E.

Health Policy. 1998 Aug;45(2):133-47.

PMID:
10186224
13.

Screening for prostate cancer: a Cochrane systematic review.

Ilic D, O'Connor D, Green S, Wilt T.

Cancer Causes Control. 2007 Apr;18(3):279-85. Epub 2007 Jan 6. Review.

PMID:
17206534
14.

The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.

Gohagan JK, Prorok PC, Hayes RB, Kramer BS; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team.

Control Clin Trials. 2000 Dec;21(6 Suppl):251S-272S.

PMID:
11189683
15.

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O'Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team.

Control Clin Trials. 2000 Dec;21(6 Suppl):273S-309S.

PMID:
11189684
16.

Statistical considerations in cancer screening programs.

Prorok PC, Connor RJ, Baker SG.

Urol Clin North Am. 1990 Nov;17(4):699-708.

PMID:
2120836
17.
18.

Cost-effectiveness studies in ovarian cancer.

Szucs TD, Wyss P, Dedes KJ.

Int J Gynecol Cancer. 2003 Nov-Dec;13 Suppl 2:212-9. Review.

PMID:
14656283
19.

Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.

McNaughton-Collins M, Walker-Corkery E, Barry MJ.

J Natl Cancer Inst Monogr. 2004;(33):78-101. Review.

PMID:
15504921
20.

Screening for prostate cancer.

Schröder FH.

Urol Clin North Am. 2003 May;30(2):239-51, viii. Review.

PMID:
12735501
Items per page

Supplemental Content

Write to the Help Desk